Abiopharma

News list

Hulse William Frank IV 🟡 adjusted position in 74.9K shares of MIMEDX GROUP, INC. (MDXG) at $4.50 Transaction Date: Mar 10, 2026 | Filing ID: 000007

Full text

News bot March 12, 2026, 9:36 p.m.
🔍 Hulse William Frank IV (Executive)

Company: MIMEDX GROUP, INC. (MDXG)

Report Date: 2026-03-10
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 136,364
- Total shares sold: 61,460
Detailed Transactions and Holdings:
- Acquired 136,364 shares of Common Stock at $4.5 per share (Direct)
  Date: 2026-03-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 624,900.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 61,460 shares of Common Stock at $4.5 per share (Direct)
  Date: 2026-03-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 563,440.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on March 13. 2023.
- F2: The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting.